Literature DB >> 18561325

Generation of dopamine neurons from embryonic stem cells in the presence of the neuralizing activity of bone marrow stromal cells derived from adult mice.

Aki Shintani1, Naoyuki Nakao, Koji Kakishita, Toru Itakura.   

Abstract

Stromal cell lines such as PA6 and MS5 have been employed for generating dopamine (DA) neurons from embryonic stem (ES) cells. The present study was designed to test whether bone marrow stromal cells (BMSC) derived from adult mice might be available as a feeder layer to produce DA cells efficiently from ES cells. When ES cells were grown on BMSC in the presence of fibroblast growth factor 8 (FGF8) and sonic hedgehog (SHH), about 40% of TuJ1-positive neurons expressed tyrosine hydroxylase (TH). Because these cells labeled with TH were negative for dopamine-beta-hydroxylasae (DBH), the marker for noradrenergic and adrenergic neurons, the TH-positive cells were most likely DA neurons. They indeed expressed midbrain DA neuron markers such as Nurr 1, Ptx-3, and c-ret and were capable of synthesizing and releasing DA in vitro. Furthermore, DA neurons differentiated from ES cells in this differentiation protocol survived transplantation in rats with 6-hydroxydopamine lesions and reversed the lesion-induced circling behavior. The data indicate that BMSC can facilitate an efficient induction of DA neurons from ES cells and that the generated DA neurons are biologically functional both in vitro and in vivo. Insofar as BMSC have recently been employed in autologous cell therapy for ischemic heart and arteriosclerotic limb diseases, the present study raises the possibility that autologous BMSC can be applied in future cell transplantation therapy in Parkinson's disease. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18561325     DOI: 10.1002/jnr.21748

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  7 in total

1.  Expression and distribution of dopamine transporter in cardiac tissues of the guinea pig.

Authors:  Alejandro Reynoso Palomar; Berenice Navarrete Larios; Victoria Chagoya De Sánchez; Lidia Martínez Pérez; Fidel De La Cruz López; Gonzalo Flores; Maria de Jesús Gómez-Villalobos
Journal:  Neurochem Res       Date:  2010-12-19       Impact factor: 3.996

2.  Axon responses of embryonic stem cell-derived dopaminergic neurons to semaphorins 3A and 3C.

Authors:  Elisa Tamariz; N Emmanuel Díaz-Martínez; Néstor F Díaz; Claudia M García-Peña; Iván Velasco; Alfredo Varela-Echavarría
Journal:  J Neurosci Res       Date:  2010-04       Impact factor: 4.164

Review 3.  Cell-based therapies for Parkinson's disease: past, present, and future.

Authors:  Kathleen M Fitzpatrick; James Raschke; Marina E Emborg
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

4.  Cellular diversity within embryonic stem cells: pluripotent clonal sublines show distinct differentiation potential.

Authors:  Yannick Martinez; Frédérique Béna; Stefania Gimelli; Diderik Tirefort; Michel Dubois-Dauphin; Karl-Heinz Krause; Olivier Preynat-Seauve
Journal:  J Cell Mol Med       Date:  2012-03       Impact factor: 5.310

5.  Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy.

Authors:  Zhaoting Li; Yixin Wang; Yuexin Shen; Chenggen Qian; David Oupicky; Minjie Sun
Journal:  Sci Adv       Date:  2020-05-15       Impact factor: 14.136

6.  Transplantation of Deprenyl-Induced Tyrosine Hydroxylase-Positive Cells Improves 6-OHDA-Lesion Rat Model of Parkinson's Disease: Behavioral and Immunohistochemical Evaluation.

Authors:  Maryam Haji Ghasem Kashani; Mohammad Taghi Ghorbanian; Leili Hosseinpour
Journal:  Cell J       Date:  2013-05-05       Impact factor: 2.479

7.  Impurity of stem cell graft by murine embryonic fibroblasts - implications for cell-based therapy of the central nervous system.

Authors:  Marek Molcanyi; Narges Zare Mehrjardi; Ute Schäfer; Nadia Nabil Haj-Yasein; Michael Brockmann; Marina Penner; Peter Riess; Clemens Reinshagen; Bernhard Rieger; Tobias Hannes; Jürgen Hescheler; Bert Bosche
Journal:  Front Cell Neurosci       Date:  2014-09-05       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.